Developing focal construct technology for in vivo diagnosis of osteoporosis
Developing focal construct technology for in vivo diagnosis of osteoporosis
复制标题
开发用于骨质疏松症体内诊断的焦点构建技术
DOI:
10.1088/1742-6596/1151/1/012020
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Greenwood C
中科院分区:
文献类型:
--
作者:
Greenwood C
Osteoporosis is a prevalent bone disease around the world, characterised by low bone mineral density and increased fracture risk. Currently, the gold standard for identifying osteoporosis and increased fracture risk is through quantification of bone mineral density (BMD), using dual energy X-ray absorption (DEXA). However, the use of BMD to diagnose osteoporosis is not without limitation and arguably the risk of osteoporotic fracture should be determined collectively by bone mass, architecture and physicochemistry of the mineral composite building blocks. Rather than depending exclusively on the'mass' of bone, our previous research investigated predicting the risk of fracture using'bone quality'. The work highlighted that the material properties of OP tissue differ significantly to that of'normal'bone and for the first time reported the clinical value of new biomarkers (obtained from X-ray scatter signatures) for fracture risk prediction. Thus, in order to improve fracture prediction models, diagnostic tools need to be developed which not only measure bone mineral density, but also bone quality.
登录
查看更多内容
影响因子:
4.1
作者:
Gadeleta, SJ;Boskey, AL;Rimnac, CM
通讯作者:
Rimnac, CM
影响因子:
5.8
作者:
Wainwright, SA;Marshall, LM;Orwoll, ES
通讯作者:
Orwoll, ES
影响因子:
4
作者:
Audrey Doublier;Audrey Doublier;D. Farlay;D. Farlay;X. Jaurand;R. Vera;G. Boivin;G. Boivin
通讯作者:
G. Boivin
影响因子:
4.1
作者:
Huang, RY;Miller, LM;Chance, MR
通讯作者:
Chance, MR
DOI:
10.1016/s0169-6009(08)80151-1
发表时间:
1994
期刊:
Bone and mineral
影响因子:
--
作者:
Lundon,K;Dumitriu,M;Grynpas,M
通讯作者:
Grynpas,M